ASCO 2015 | Current clinical perspectives on targeted therapy and immunotherapy for melanoma
Caroline Robert • 30 May 2015
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Caroline Robert, MD, PhD, from Institut Gustave Roussy, Villejuif, France, considers the impact of available and emerging targeted therapies and immunotherapies on the current treatment landscape in melanoma.
